The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004
- PMID: 19022533
- PMCID: PMC4762027
- DOI: 10.1016/j.jaad.2008.09.022
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004
Erratum in
- J Am Acad Dermatol. 2009 Sep;61(3):507
Abstract
Background: Psoriasis is a predictor of morbidity. It is important to determine the extent to which psoriasis remains undiagnosed.
Objective: To determine the prevalence of psoriasis.
Methods: We conducted a cross-sectional study using the National Health and Nutrition Examination Survey 2003-2004.
Results: The prevalence of diagnosed psoriasis was 3.15% (95% confidence interval [CI], 2.18-4.53), corresponding to 5 million adults. Approximately 17% of these patients have moderate to severe psoriasis based on body surface area report and 25% rate psoriasis a large problem in everyday life. The prevalence of undiagnosed active psoriasis by conservative estimate was 0.4% (95% CI, 0.19-0.82), corresponding to approximately 600,000 US adults, and 2.28% (95% CI, 1.47-3.50) by a broader definition, corresponding to 3.6 million US adults. Undiagnosed patients had a trend toward being more likely to be male, nonwhite, less educated, and unmarried compared with patients who had received a diagnosis.
Limitations: The method for determining the presence of psoriasis had limited ability to detect mild disease and only fair interrater agreement.
Conclusion: More than 5 million adults have been diagnosed with psoriasis. A large number have undiagnosed psoriasis and there are important disparities which may be associated with not receiving medical attention.
Conflict of interest statement
References
-
- Gelfand JM, Troxel AB, Lewis JD, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol. 2007;143:1493–1499. - PubMed
-
- Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. Jama. 2006;296:1735–1741. - PubMed
-
- Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–835. - PubMed
-
- Kurd S, Richardson S, Gelfand J. An Update on the Epidemiology and Systemic Treatment of Psoriasis. Expert Review of Clinical Immunology. 2007;3:171–185. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical